Journey Strategic Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
10,401
+4,053
| +64% | +$449K | 0.04% | 144 |
|
|
2025
Q1 | $711K | Buy |
6,348
+435
| +7% | +$48.7K | 0.02% | 179 |
|
|
2024
Q4 | $546K | Buy |
5,913
+288
| +5% | +$26.6K | 0.02% | 203 |
|
|
2024
Q3 | $472K | Buy |
5,625
+995
| +21% | +$83.4K | 0.02% | 227 |
|
|
2024
Q2 | $318K | Buy |
4,630
+1,741
| +60% | +$119K | 0.01% | 235 |
|
|
2024
Q1 | $212K | Buy |
2,889
+400
| +16% | +$29.3K | 0.01% | 276 |
|
|
2023
Q4 | $202K | Buy |
+2,489
| New | +$202K | 0.01% | 205 |
|
|
2023
Q2 | – | Sell |
-3,785
| Closed | -$314K | – | 231 |
|
|
2023
Q1 | $314K | Buy |
3,785
+370
| +11% | +$30.7K | 0.03% | 151 |
|
|
2022
Q4 | $293K | Buy |
+3,415
| New | +$293K | 0.03% | 144 |
|
|
2022
Q1 | – | Sell |
-3,572
| Closed | -$259K | – | 199 |
|
|
2021
Q4 | $259K | Buy |
+3,572
| New | +$259K | 0.03% | 142 |
|